These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Fine tuning of receptor-selectivity for tumor necrosis factor-α using a phage display system with one-step competitive panning. Abe Y; Yoshikawa T; Inoue M; Nomura T; Furuya T; Yamashita T; Nagano K; Nabeshi H; Yoshioka Y; Mukai Y; Nakagawa S; Kamada H; Tsutsumi Y; Tsunoda S Biomaterials; 2011 Aug; 32(23):5498-504. PubMed ID: 21546081 [TBL] [Abstract][Full Text] [Related]
8. A trimeric structural fusion of an antagonistic tumor necrosis factor-α mutant enhances molecular stability and enables facile modification. Inoue M; Ando D; Kamada H; Taki S; Niiyama M; Mukai Y; Tadokoro T; Maenaka K; Nakayama T; Kado Y; Inoue T; Tsutsumi Y; Tsunoda SI J Biol Chem; 2017 Apr; 292(16):6438-6451. PubMed ID: 28235800 [TBL] [Abstract][Full Text] [Related]
9. [Development of New Biologics through Creation of a Functional Cytokine Mutant]. Kamada H Yakugaku Zasshi; 2015; 135(7):843-9. PubMed ID: 26135083 [TBL] [Abstract][Full Text] [Related]
10. Generation of mouse macrophages expressing membrane-bound TNF variants with selectivity for TNFR1 or TNFR2. Shibata H; Abe Y; Yoshioka Y; Nomura T; Sato M; Kayamuro H; Kawara T; Arita S; Furuya T; Nagano K; Yoshikawa T; Kamada H; Tsunoda S; Tsutsumi Y Cytokine; 2010 Apr; 50(1):75-83. PubMed ID: 20045350 [TBL] [Abstract][Full Text] [Related]
12. A novel domain antibody rationally designed against TNF-alpha using variable region of human heavy chain antibody as scaffolds to display antagonistic peptides. Qin W; Feng J; Li Y; Lin Z; Shen B Mol Immunol; 2007 Mar; 44(9):2355-61. PubMed ID: 17125837 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and Pharmacodynamic Characterisation of an Anti-Mouse TNF Receptor 1 Domain Antibody Formatted for In Vivo Half-Life Extension. Goodall LJ; Ovecka M; Rycroft D; Friel SL; Sanderson A; Mistry P; Davies ML; Stoop AA PLoS One; 2015; 10(9):e0137065. PubMed ID: 26352810 [TBL] [Abstract][Full Text] [Related]
15. Essential protective role of tumor necrosis factor receptor 2 in neurodegeneration. Dong Y; Fischer R; Naudé PJ; Maier O; Nyakas C; Duffey M; Van der Zee EA; Dekens D; Douwenga W; Herrmann A; Guenzi E; Kontermann RE; Pfizenmaier K; Eisel UL Proc Natl Acad Sci U S A; 2016 Oct; 113(43):12304-12309. PubMed ID: 27791020 [TBL] [Abstract][Full Text] [Related]
16. A humanized tumor necrosis factor receptor 1 (TNFR1)-specific antagonistic antibody for selective inhibition of tumor necrosis factor (TNF) action. Kontermann RE; Münkel S; Neumeyer J; Müller D; Branschädel M; Scheurich P; Pfizenmaier K J Immunother; 2008 Apr; 31(3):225-34. PubMed ID: 18317365 [TBL] [Abstract][Full Text] [Related]
17. Interaction between transmembrane TNF and TNFR1/2 mediates the activation of monocytes by contact with T cells. Rossol M; Meusch U; Pierer M; Kaltenhäuser S; Häntzschel H; Hauschildt S; Wagner U J Immunol; 2007 Sep; 179(6):4239-48. PubMed ID: 17785864 [TBL] [Abstract][Full Text] [Related]
18. Evoked pain behavior and spinal glia activation is dependent on tumor necrosis factor receptor 1 and 2 in a mouse model of bone cancer pain. Geis C; Graulich M; Wissmann A; Hagenacker T; Thomale J; Sommer C; Schäfers M Neuroscience; 2010 Aug; 169(1):463-74. PubMed ID: 20417692 [TBL] [Abstract][Full Text] [Related]
19. Lack of Evidence for a Direct Interaction of Progranulin and Tumor Necrosis Factor Receptor-1 and Tumor Necrosis Factor Receptor-2 From Cellular Binding Studies. Lang I; Füllsack S; Wajant H Front Immunol; 2018; 9():793. PubMed ID: 29740434 [TBL] [Abstract][Full Text] [Related]
20. Effects of bovine tumor necrosis factor alpha decoy receptors on cell death and inflammatory cytokine kinetics: potential for bovine inflammation therapy. Fujisawa S; Konnai S; Okagawa T; Maekawa N; Tanaka A; Suzuki Y; Murata S; Ohashi K BMC Vet Res; 2019 Feb; 15(1):68. PubMed ID: 30819151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]